SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5efn'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C3S_A_SHHA952_1 (HDLP (HISTONE DEACETYLASE-LIKE PROTEIN))	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 11	HIS B 573 HIS B 614 ASP B 705 LEU B 712 TYR B 745	None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None None	1.20A	1c3sA-5efnB: 41.1	1c3sA-5efnB: 27.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C3S_A_SHHA952_1 (HDLP (HISTONE DEACETYLASE-LIKE PROTEIN))	5efn	HDAC6 PROTEIN (Danio rerio)	9 / 11	PRO B 464 HIS B 573 PHE B 583 ASP B 612 HIS B 614 PHE B 643 ASP B 705 LEU B 712 TYR B 745	None None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) None None	0.55A	1c3sA-5efnB: 41.1	1c3sA-5efnB: 27.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FDU_C_ESTC353_1 (17-BETA-HYDROXYSTERO ID DEHYDROGENASE)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 12	GLY B 721 LEU B 725 TYR B 722 GLY B 674 VAL B 686	None	1.09A	1fduC-5efnB: 3.6	1fduC-5efnB: 23.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HRK_A_CHDA1502_0 (FERROCHELATASE)	5efn	HDAC6 PROTEIN (Danio rerio)	4 / 8	MET B 687 PRO B 695 VAL B 737 GLY B 735	None	0.95A	1hrkA-5efnB: 2.1	1hrkA-5efnB: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HRK_B_CHDB2502_0 (FERROCHELATASE)	5efn	HDAC6 PROTEIN (Danio rerio)	4 / 8	MET B 687 PRO B 695 VAL B 737 GLY B 735	None	0.92A	1hrkB-5efnB: 2.1	1hrkB-5efnB: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KB9_A_PCFA514_0 (CYTOCHROME B CYTOCHROME C1, HEME PROTEIN UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX CORE PROTEIN I UBIQUINOL-CYTOCHROME C REDUCTASE IRON-SULFUR SUBUNIT)	5efn	HDAC6 PROTEIN (Danio rerio)	4 / 8	SER B 701 ILE B 622 PHE B 623 VAL B 606	None	0.91A	1kb9A-5efnB: undetectable 1kb9C-5efnB: undetectable 1kb9D-5efnB: undetectable 1kb9E-5efnB: undetectable	1kb9A-5efnB: 23.44 1kb9C-5efnB: 20.78 1kb9D-5efnB: 21.54 1kb9E-5efnB: 21.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MXG_A_ACRA442_1 (ALPHA AMYLASE)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 11	GLY B 616 GLY B 572 GLY B 703 GLY B 743 ASP B 705	None None None ZN B 801 ( 4.1A) ZN B 801 (-2.6A)	1.12A	1mxgA-5efnB: undetectable	1mxgA-5efnB: 22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T69_A_SHHA379_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	8 / 12	HIS B 573 GLY B 582 PHE B 583 ASP B 612 HIS B 614 PHE B 643 ASP B 705 TYR B 745	None None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) None	0.42A	1t69A-5efnB: 41.4	1t69A-5efnB: 28.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ZZ1_A_SHHA2452_1 (HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 11	HIS B 573 HIS B 614 ASP B 705 GLY B 744 TYR B 745	None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None None	1.24A	1zz1A-5efnB: 50.0	1zz1A-5efnB: 33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ZZ1_A_SHHA2452_1 (HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE)	5efn	HDAC6 PROTEIN (Danio rerio)	8 / 11	HIS B 573 PHE B 583 ASP B 612 HIS B 614 PHE B 643 ASP B 705 GLY B 743 TYR B 745	None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) ZN B 801 ( 4.1A) None	0.44A	1zz1A-5efnB: 50.0	1zz1A-5efnB: 33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ZZ1_A_SHHA2452_1 (HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE)	5efn	HDAC6 PROTEIN (Danio rerio)	7 / 11	ILE B 532 HIS B 573 ASP B 612 HIS B 614 ASP B 705 GLY B 743 TYR B 745	None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) ZN B 801 (-2.6A) ZN B 801 ( 4.1A) None	1.06A	1zz1A-5efnB: 50.0	1zz1A-5efnB: 33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ZZ1_B_SHHB2552_1 (HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 12	HIS B 573 HIS B 614 ASP B 705 GLY B 743 TYR B 745	None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) ZN B 801 ( 4.1A) None	1.10A	1zz1B-5efnB: 50.5 1zz1C-5efnB: 50.4	1zz1B-5efnB: 33.16 1zz1C-5efnB: 33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ZZ1_B_SHHB2552_1 (HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE)	5efn	HDAC6 PROTEIN (Danio rerio)	8 / 12	HIS B 573 PHE B 583 ASP B 612 HIS B 614 PHE B 643 ASP B 705 GLY B 743 TYR B 745	None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) ZN B 801 ( 4.1A) None	0.39A	1zz1B-5efnB: 50.5 1zz1C-5efnB: 50.4	1zz1B-5efnB: 33.16 1zz1C-5efnB: 33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ZZ1_C_SHHC2652_1 (HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE)	5efn	HDAC6 PROTEIN (Danio rerio)	9 / 12	ILE B 532 HIS B 573 GLY B 582 ASP B 612 HIS B 614 PHE B 643 ASP B 705 GLY B 743 TYR B 745	None None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) ZN B 801 ( 4.1A) None	1.42A	1zz1C-5efnB: 50.4	1zz1C-5efnB: 33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ZZ1_C_SHHC2652_1 (HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 12	ILE B 532 HIS B 614 GLY B 582 ASP B 705 GLY B 743	None ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) ZN B 801 ( 4.1A)	1.09A	1zz1C-5efnB: 50.4	1zz1C-5efnB: 33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ZZ1_D_SHHD2752_1 (HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE)	5efn	HDAC6 PROTEIN (Danio rerio)	7 / 9	HIS B 573 PHE B 583 ASP B 612 HIS B 614 PHE B 643 ASP B 705 TYR B 745	None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) None	0.42A	1zz1D-5efnB: 50.2	1zz1D-5efnB: 33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ZZ1_D_SHHD2752_1 (HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 9	ILE B 532 HIS B 573 ASP B 612 ASP B 705 TYR B 745	None None ZN B 801 ( 2.1A) ZN B 801 (-2.6A) None	0.98A	1zz1D-5efnB: 50.2	1zz1D-5efnB: 33.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EJ3_A_GBNA2414_1 (BRANCHED-CHAIN AMINO ACID AMINOTRANSFERASE)	5efn	HDAC6 PROTEIN (Danio rerio)	4 / 8	GLY B 618 THR B 588 ALA B 589 ALA B 590	None	0.59A	2ej3A-5efnB: undetectable	2ej3A-5efnB: 20.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OAX_F_SNLF6001_2 (MINERALOCORTICOID RECEPTOR)	5efn	HDAC6 PROTEIN (Danio rerio)	4 / 5	LEU B 732 LEU B 729 MET B 687 MET B 679	None	0.75A	2oaxF-5efnB: undetectable	2oaxF-5efnB: 21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_C_CTCC1385_0 (TETX2 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 12	PHE B 583 HIS B 573 GLY B 582 SER B 531 GLY B 713	None	1.36A	2y6rC-5efnB: undetectable	2y6rC-5efnB: 21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A25_A_SAMA279_1 (UNCHARACTERIZED PROTEIN PH0793)	5efn	HDAC6 PROTEIN (Danio rerio)	3 / 3	MET B 452 GLU B 465 ASP B 705	None None ZN B 801 (-2.6A)	1.00A	3a25A-5efnB: undetectable	3a25A-5efnB: 23.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BPX_A_SALA257_1 (TRANSCRIPTIONAL REGULATOR)	5efn	HDAC6 PROTEIN (Danio rerio)	4 / 8	ALA B 545 CYH B 549 ILE B 740 THR B 588	None	0.73A	3bpxA-5efnB: undetectable 3bpxB-5efnB: undetectable	3bpxA-5efnB: 16.90 3bpxB-5efnB: 16.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3C0Z_A_SHHA301_1 (HISTONE DEACETYLASE 7A)	5efn	HDAC6 PROTEIN (Danio rerio)	4 / 5	HIS B 573 ASP B 612 HIS B 614 ASP B 705	None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) ZN B 801 (-2.6A)	0.10A	3c0zA-5efnB: 56.6	3c0zA-5efnB: 41.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3C0Z_B_SHHB301_1 (HISTONE DEACETYLASE 7A)	5efn	HDAC6 PROTEIN (Danio rerio)	7 / 8	HIS B 573 PHE B 583 ASP B 612 HIS B 614 PHE B 643 ASP B 705 GLY B 743	None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) ZN B 801 ( 4.1A)	0.35A	3c0zB-5efnB: 56.1	3c0zB-5efnB: 41.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3C0Z_B_SHHB301_1 (HISTONE DEACETYLASE 7A)	5efn	HDAC6 PROTEIN (Danio rerio)	4 / 8	PHE B 643 ASP B 705 PHE B 583 ASP B 612	None ZN B 801 (-2.6A) None ZN B 801 ( 2.1A)	0.90A	3c0zB-5efnB: 56.1	3c0zB-5efnB: 41.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3C0Z_C_SHHC301_1 (HISTONE DEACETYLASE 7A)	5efn	HDAC6 PROTEIN (Danio rerio)	4 / 6	HIS B 573 ASP B 612 HIS B 614 ASP B 705	None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) ZN B 801 (-2.6A)	0.15A	3c0zC-5efnB: 56.0	3c0zC-5efnB: 41.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CLB_B_TMQB612_1 (DHFR-TS)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 12	ALA B 580 ILE B 534 PHE B 586 SER B 514 ILE B 508	None	1.23A	3clbB-5efnB: undetectable	3clbB-5efnB: 21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CO4_A_GCSA401_1 (CHITINASE)	5efn	HDAC6 PROTEIN (Danio rerio)	3 / 3	GLU B 576 HIS B 573 HIS B 615	EDO B 805 (-4.3A) None None	0.82A	3co4A-5efnB: undetectable	3co4A-5efnB: 19.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JQ7_B_DX2B271_1 (PTERIDINE REDUCTASE 1)	5efn	HDAC6 PROTEIN (Danio rerio)	4 / 8	ARG B 469 SER B 749 PHE B 704 TYR B 722	None	1.12A	3jq7B-5efnB: 5.3	3jq7B-5efnB: 22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JQA_B_DX4B270_0 (PTERIDINE REDUCTASE 1)	5efn	HDAC6 PROTEIN (Danio rerio)	4 / 6	ARG B 469 SER B 749 PHE B 704 TYR B 722	None	1.11A	3jqaB-5efnB: 5.2	3jqaB-5efnB: 22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JQA_C_DX4C270_0 (PTERIDINE REDUCTASE 1)	5efn	HDAC6 PROTEIN (Danio rerio)	4 / 6	ARG B 469 SER B 749 PHE B 704 TYR B 722	None	1.11A	3jqaC-5efnB: undetectable	3jqaC-5efnB: 22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JQA_D_DX4D270_0 (PTERIDINE REDUCTASE 1)	5efn	HDAC6 PROTEIN (Danio rerio)	4 / 6	ARG B 469 SER B 749 PHE B 704 TYR B 722	None	1.13A	3jqaD-5efnB: 3.0	3jqaD-5efnB: 22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RUN_A_CCSA165_0 (LYSOZYME)	5efn	HDAC6 PROTEIN (Danio rerio)	3 / 3	ASN B 665 ALA B 649 LYS B 653	None	0.90A	3runA-5efnB: undetectable	3runA-5efnB: 17.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V3N_A_MIYA2001_1 (TETX2 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 11	PHE B 583 HIS B 573 GLY B 582 SER B 531 GLY B 713	None	1.39A	3v3nA-5efnB: 1.3	3v3nA-5efnB: 24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V3N_D_MIYD2001_1 (TETX2 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 11	PHE B 583 HIS B 573 GLY B 582 SER B 531 GLY B 713	None	1.40A	3v3nD-5efnB: undetectable	3v3nD-5efnB: 24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V3O_C_T1CC401_1 (TETX2 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 11	PHE B 583 HIS B 573 GLY B 582 SER B 531 GLY B 713	None	1.41A	3v3oC-5efnB: undetectable	3v3oC-5efnB: 24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AFG_C_QMRC1214_1 (CAPITELLA TELETA ACHBP)	5efn	HDAC6 PROTEIN (Danio rerio)	4 / 8	TYR B 722 CYH B 757 ILE B 567 ILE B 739	None	0.82A	4afgD-5efnB: undetectable 4afgE-5efnB: undetectable	4afgD-5efnB: 19.67 4afgE-5efnB: 19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BBO_C_ACTC1113_0 (BLR5658 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	4 / 4	ASN B 617 ALA B 574 GLY B 618 THR B 619	None	1.17A	4bboC-5efnB: undetectable	4bboC-5efnB: 15.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BZ6_A_SHHA700_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	7 / 10	HIS B 573 ASP B 612 HIS B 614 ASP B 705 PRO B 711 GLY B 743 TYR B 745	None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None ZN B 801 ( 4.1A) None	0.39A	4bz6A-5efnB: 40.8	4bz6A-5efnB: 26.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BZ6_A_SHHA700_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 10	HIS B 573 HIS B 614 ASP B 705 GLY B 744 TYR B 745	None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None None	1.22A	4bz6A-5efnB: 40.8	4bz6A-5efnB: 26.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BZ6_A_SHHA700_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	6 / 10	HIS B 573 HIS B 614 ASP B 705 PRO B 711 GLY B 743 TYR B 745	None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None ZN B 801 ( 4.1A) None	1.10A	4bz6A-5efnB: 40.8	4bz6A-5efnB: 26.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BZ6_B_SHHB700_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	8 / 12	HIS B 573 ASP B 612 HIS B 614 PHE B 643 ASP B 705 PRO B 711 GLY B 743 TYR B 745	None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) None ZN B 801 ( 4.1A) None	0.52A	4bz6A-5efnB: 40.8 4bz6B-5efnB: 40.6	4bz6A-5efnB: 26.07 4bz6B-5efnB: 26.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BZ6_B_SHHB700_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 12	HIS B 573 HIS B 614 ASP B 705 GLY B 744 TYR B 745	None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None None	1.20A	4bz6A-5efnB: 40.8 4bz6B-5efnB: 40.6	4bz6A-5efnB: 26.07 4bz6B-5efnB: 26.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BZ6_B_SHHB700_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	6 / 12	HIS B 573 HIS B 614 ASP B 705 PRO B 711 GLY B 743 TYR B 745	None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None ZN B 801 ( 4.1A) None	1.11A	4bz6A-5efnB: 40.8 4bz6B-5efnB: 40.6	4bz6A-5efnB: 26.07 4bz6B-5efnB: 26.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BZ6_C_SHHC700_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	9 / 12	HIS B 573 GLY B 582 ASP B 612 HIS B 614 PHE B 643 ASP B 705 PRO B 711 GLY B 743 TYR B 745	None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) None ZN B 801 ( 4.1A) None	0.56A	4bz6C-5efnB: 40.7	4bz6C-5efnB: 26.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BZ6_C_SHHC700_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 12	HIS B 573 HIS B 614 ASP B 705 GLY B 744 TYR B 745	None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None None	1.20A	4bz6C-5efnB: 40.7	4bz6C-5efnB: 26.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BZ6_C_SHHC700_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	6 / 12	HIS B 573 HIS B 614 ASP B 705 PRO B 711 GLY B 743 TYR B 745	None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None ZN B 801 ( 4.1A) None	1.09A	4bz6C-5efnB: 40.7	4bz6C-5efnB: 26.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BZ6_D_SHHD700_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	7 / 10	HIS B 573 ASP B 612 HIS B 614 ASP B 705 PRO B 711 GLY B 743 TYR B 745	None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None ZN B 801 ( 4.1A) None	0.39A	4bz6D-5efnB: 40.8	4bz6D-5efnB: 26.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BZ6_D_SHHD700_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 10	HIS B 573 HIS B 614 ASP B 705 GLY B 744 TYR B 745	None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None None	1.21A	4bz6D-5efnB: 40.8	4bz6D-5efnB: 26.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BZ6_D_SHHD700_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	6 / 10	HIS B 573 HIS B 614 ASP B 705 PRO B 711 GLY B 743 TYR B 745	None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None ZN B 801 ( 4.1A) None	1.10A	4bz6D-5efnB: 40.8	4bz6D-5efnB: 26.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DJE_A_C2FA300_0 (5-METHYLTETRAHYDROFO LATE CORRINOID/IRON SULFUR PROTEIN METHYLTRANSFERASE)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 12	GLU B 465 PHE B 533 ASP B 710 GLY B 744 GLN B 468	None	1.43A	4djeA-5efnB: undetectable	4djeA-5efnB: 20.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LXZ_A_SHHA407_1 (HISTONE DEACETYLASE 2)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 12	HIS B 463 HIS B 614 ASP B 705 GLY B 744 TYR B 745	None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None None	1.20A	4lxzA-5efnB: 43.7	4lxzA-5efnB: 27.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LXZ_A_SHHA407_1 (HISTONE DEACETYLASE 2)	5efn	HDAC6 PROTEIN (Danio rerio)	10 / 12	HIS B 463 PRO B 464 HIS B 573 GLY B 582 PHE B 583 ASP B 612 HIS B 614 ASP B 705 GLY B 743 TYR B 745	None None None None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) ZN B 801 (-2.6A) ZN B 801 ( 4.1A) None	0.49A	4lxzA-5efnB: 43.7	4lxzA-5efnB: 27.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LXZ_A_SHHA407_1 (HISTONE DEACETYLASE 2)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 12	HIS B 573 HIS B 614 ASP B 705 GLY B 743 TYR B 745	None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) ZN B 801 ( 4.1A) None	1.04A	4lxzA-5efnB: 43.7	4lxzA-5efnB: 27.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LXZ_B_SHHB408_1 (HISTONE DEACETYLASE 2)	5efn	HDAC6 PROTEIN (Danio rerio)	9 / 11	HIS B 463 PRO B 464 HIS B 573 PHE B 583 ASP B 612 HIS B 614 ASP B 705 GLY B 743 TYR B 745	None None None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) ZN B 801 (-2.6A) ZN B 801 ( 4.1A) None	0.48A	4lxzB-5efnB: 43.6	4lxzB-5efnB: 27.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LXZ_B_SHHB408_1 (HISTONE DEACETYLASE 2)	5efn	HDAC6 PROTEIN (Danio rerio)	6 / 11	HIS B 463 PRO B 464 HIS B 614 ASP B 705 GLY B 744 TYR B 745	None None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None None	1.18A	4lxzB-5efnB: 43.6	4lxzB-5efnB: 27.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LXZ_B_SHHB408_1 (HISTONE DEACETYLASE 2)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 11	HIS B 573 HIS B 614 ASP B 705 GLY B 743 TYR B 745	None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) ZN B 801 ( 4.1A) None	1.07A	4lxzB-5efnB: 43.6	4lxzB-5efnB: 27.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LXZ_C_SHHC406_1 (HISTONE DEACETYLASE 2)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 12	HIS B 573 HIS B 614 ASP B 705 GLY B 743 TYR B 745	None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) ZN B 801 ( 4.1A) None	1.06A	4lxzC-5efnB: 43.7	4lxzC-5efnB: 27.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LXZ_C_SHHC406_1 (HISTONE DEACETYLASE 2)	5efn	HDAC6 PROTEIN (Danio rerio)	10 / 12	PRO B 464 HIS B 573 GLY B 582 PHE B 583 ASP B 612 HIS B 614 PHE B 643 ASP B 705 GLY B 743 TYR B 745	None None None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) ZN B 801 ( 4.1A) None	0.43A	4lxzC-5efnB: 43.7	4lxzC-5efnB: 27.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LXZ_C_SHHC406_1 (HISTONE DEACETYLASE 2)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 12	PRO B 464 HIS B 614 ASP B 705 GLY B 744 TYR B 745	None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None None	1.14A	4lxzC-5efnB: 43.7	4lxzC-5efnB: 27.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LXZ_C_SHHC406_1 (HISTONE DEACETYLASE 2)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 12	PRO B 570 HIS B 614 GLY B 582 ASP B 705 GLY B 743	None ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) ZN B 801 ( 4.1A)	1.23A	4lxzC-5efnB: 43.7	4lxzC-5efnB: 27.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QA0_A_SHHA404_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	9 / 12	HIS B 573 GLY B 582 PHE B 583 ASP B 612 HIS B 614 PHE B 643 ASP B 705 GLY B 743 TYR B 745	None None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) ZN B 801 ( 4.1A) None	0.46A	4qa0A-5efnB: 41.8	4qa0A-5efnB: 27.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QA0_A_SHHA404_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	6 / 12	HIS B 573 PHE B 583 HIS B 614 ASP B 705 GLY B 744 TYR B 745	None None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None None	1.22A	4qa0A-5efnB: 41.8	4qa0A-5efnB: 27.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QA0_A_SHHA404_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	6 / 12	PHE B 583 HIS B 614 PHE B 643 ASP B 705 GLY B 744 TYR B 745	None ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) None None	1.26A	4qa0A-5efnB: 41.8	4qa0A-5efnB: 27.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QA0_B_SHHB404_2 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	8 / 11	HIS B 573 PHE B 583 ASP B 612 HIS B 614 PHE B 643 ASP B 705 GLY B 743 TYR B 745	None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) ZN B 801 ( 4.1A) None	0.50A	4qa0B-5efnB: 41.7	4qa0B-5efnB: 27.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QA0_B_SHHB404_2 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	6 / 11	HIS B 573 PHE B 583 HIS B 614 ASP B 705 GLY B 744 TYR B 745	None None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None None	1.23A	4qa0B-5efnB: 41.7	4qa0B-5efnB: 27.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QA0_B_SHHB404_2 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	6 / 11	PHE B 583 HIS B 614 PHE B 643 ASP B 705 GLY B 744 TYR B 745	None ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) None None	1.25A	4qa0B-5efnB: 41.7	4qa0B-5efnB: 27.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QA2_A_SHHA404_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	9 / 12	HIS B 573 GLY B 582 PHE B 583 ASP B 612 HIS B 614 PHE B 643 ASP B 705 GLY B 743 TYR B 745	None None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) ZN B 801 ( 4.1A) None	0.48A	4qa2A-5efnB: 41.6	4qa2A-5efnB: 27.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QA2_A_SHHA404_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 12	HIS B 573 HIS B 614 ASP B 705 GLY B 744 TYR B 745	None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None None	1.20A	4qa2A-5efnB: 41.6	4qa2A-5efnB: 27.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QA2_A_SHHA404_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	6 / 12	PHE B 583 HIS B 614 PHE B 643 ASP B 705 GLY B 744 TYR B 745	None ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) None None	1.23A	4qa2A-5efnB: 41.6	4qa2A-5efnB: 27.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QA2_B_SHHB404_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	9 / 12	HIS B 573 GLY B 582 PHE B 583 ASP B 612 HIS B 614 PHE B 643 ASP B 705 GLY B 743 TYR B 745	None None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) ZN B 801 ( 4.1A) None	0.44A	4qa2B-5efnB: 41.9	4qa2B-5efnB: 27.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QA2_B_SHHB404_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 12	HIS B 573 HIS B 614 ASP B 705 GLY B 744 TYR B 745	None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None None	1.20A	4qa2B-5efnB: 41.9	4qa2B-5efnB: 27.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QA2_B_SHHB404_1 (HISTONE DEACETYLASE 8)	5efn	HDAC6 PROTEIN (Danio rerio)	6 / 12	PHE B 583 HIS B 614 PHE B 643 ASP B 705 GLY B 744 TYR B 745	None ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) None None	1.22A	4qa2B-5efnB: 41.9	4qa2B-5efnB: 27.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5EEI_A_SHHA2004_1 (HDAC6 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	6 / 12	PRO B 464 HIS B 573 HIS B 614 ASP B 705 LEU B 712 TYR B 745	None None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None None	1.03A	5eeiA-5efnB: 69.6	5eeiA-5efnB: 99.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5EEI_A_SHHA2004_1 (HDAC6 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	11 / 12	PRO B 464 SER B 531 HIS B 573 GLY B 582 PHE B 583 ASP B 612 HIS B 614 PHE B 643 ASP B 705 LEU B 712 TYR B 745	None None None None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) None None	0.47A	5eeiA-5efnB: 69.6	5eeiA-5efnB: 99.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5EEI_B_SHHB801_1 (HDAC6 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	6 / 12	PRO B 464 HIS B 573 HIS B 614 ASP B 705 LEU B 712 TYR B 745	None None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None None	1.03A	5eeiB-5efnB: 68.3	5eeiB-5efnB: 99.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5EEI_B_SHHB801_1 (HDAC6 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	11 / 12	PRO B 464 SER B 531 HIS B 573 GLY B 582 PHE B 583 ASP B 612 HIS B 614 PHE B 643 ASP B 705 LEU B 712 TYR B 745	None None None None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) None None	0.47A	5eeiB-5efnB: 68.3	5eeiB-5efnB: 99.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5EEN_A_5OGA804_1 (HDAC6 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	6 / 12	HIS B 463 HIS B 614 PHE B 643 ASP B 705 GLY B 744 TYR B 745	None ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) None None	1.27A	5eenA-5efnB: 68.2	5eenA-5efnB: 99.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5EEN_A_5OGA804_1 (HDAC6 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	10 / 12	HIS B 463 PRO B 464 HIS B 573 PHE B 583 ASP B 612 HIS B 614 PHE B 643 ASP B 705 GLY B 743 TYR B 745	None None None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) ZN B 801 ( 4.1A) None	0.23A	5eenA-5efnB: 68.2	5eenA-5efnB: 99.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5EEN_A_5OGA804_1 (HDAC6 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 12	HIS B 573 ASP B 612 HIS B 614 ASP B 705 GLY B 703	None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None	1.19A	5eenA-5efnB: 68.2	5eenA-5efnB: 99.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5EEN_A_5OGA804_1 (HDAC6 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	6 / 12	PRO B 464 HIS B 573 HIS B 614 ASP B 705 GLY B 743 TYR B 745	None None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) ZN B 801 ( 4.1A) None	1.11A	5eenA-5efnB: 68.2	5eenA-5efnB: 99.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5EEN_A_5OGA804_1 (HDAC6 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	8 / 12	SER B 531 HIS B 573 PHE B 583 ASP B 612 HIS B 614 PHE B 643 ASP B 705 GLY B 743	None None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) ZN B 801 ( 4.1A)	0.59A	5eenA-5efnB: 68.2	5eenA-5efnB: 99.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5EEN_A_5OGA804_1 (HDAC6 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 12	SER B 531 PHE B 643 ASP B 705 PHE B 583 ASP B 612	None None ZN B 801 (-2.6A) None ZN B 801 ( 2.1A)	1.17A	5eenA-5efnB: 68.2	5eenA-5efnB: 99.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5EEN_B_5OGB804_1 (HDAC6 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	10 / 12	HIS B 463 PRO B 464 HIS B 573 PHE B 583 ASP B 612 HIS B 614 PHE B 643 ASP B 705 LEU B 712 TYR B 745	None None None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) None None	0.29A	5eenB-5efnB: 67.7	5eenB-5efnB: 99.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5EEN_B_5OGB804_1 (HDAC6 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	6 / 12	PRO B 464 HIS B 573 HIS B 614 ASP B 705 LEU B 712 TYR B 745	None None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None None	1.01A	5eenB-5efnB: 67.7	5eenB-5efnB: 99.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5EEN_B_5OGB804_1 (HDAC6 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	9 / 12	SER B 531 HIS B 573 PHE B 583 ASP B 612 HIS B 614 PHE B 643 ASP B 705 LEU B 712 TYR B 745	None None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) None None	0.57A	5eenB-5efnB: 67.7	5eenB-5efnB: 99.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5EEN_B_5OGB804_1 (HDAC6 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 12	SER B 531 PHE B 643 ASP B 705 PHE B 583 ASP B 612	None None ZN B 801 (-2.6A) None ZN B 801 ( 2.1A)	1.17A	5eenB-5efnB: 67.7	5eenB-5efnB: 99.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5EF8_A_LBHA2004_1 (HDAC6 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	10 / 12	ASP B 460 HIS B 463 PRO B 464 HIS B 573 PHE B 583 ASP B 612 HIS B 614 PHE B 643 ASP B 705 TYR B 745	None None None None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) None	0.22A	5ef8A-5efnB: 67.6	5ef8A-5efnB: 99.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5EF8_A_LBHA2004_1 (HDAC6 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	9 / 12	ASP B 460 SER B 531 HIS B 573 PHE B 583 ASP B 612 HIS B 614 PHE B 643 ASP B 705 TYR B 745	None None None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) None	0.54A	5ef8A-5efnB: 67.6	5ef8A-5efnB: 99.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5EF8_A_LBHA2004_1 (HDAC6 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 12	SER B 531 PHE B 643 ASP B 705 PHE B 583 ASP B 612	None None ZN B 801 (-2.6A) None ZN B 801 ( 2.1A)	1.16A	5ef8A-5efnB: 67.6	5ef8A-5efnB: 99.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5EF8_B_LBHB2004_1 (HDAC6 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	10 / 12	ASP B 460 PRO B 464 HIS B 573 PHE B 583 ASP B 612 HIS B 614 PHE B 643 ASP B 705 LEU B 712 TYR B 745	None None None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) None None	0.29A	5ef8B-5efnB: 67.6	5ef8B-5efnB: 99.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5EF8_B_LBHB2004_1 (HDAC6 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	10 / 12	ASP B 460 SER B 531 HIS B 573 PHE B 583 ASP B 612 HIS B 614 PHE B 643 ASP B 705 LEU B 712 TYR B 745	None None None None ZN B 801 ( 2.1A) ZN B 801 ( 3.2A) None ZN B 801 (-2.6A) None None	0.55A	5ef8B-5efnB: 67.6	5ef8B-5efnB: 99.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5EF8_B_LBHB2004_1 (HDAC6 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	6 / 12	PRO B 464 HIS B 573 HIS B 614 ASP B 705 LEU B 712 TYR B 745	None None ZN B 801 ( 3.2A) ZN B 801 (-2.6A) None None	0.98A	5ef8B-5efnB: 67.6	5ef8B-5efnB: 99.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5EF8_B_LBHB2004_1 (HDAC6 PROTEIN)	5efn	HDAC6 PROTEIN (Danio rerio)	5 / 12	SER B 531 PHE B 643 ASP B 705 PHE B 583 ASP B 612	None None ZN B 801 (-2.6A) None ZN B 801 ( 2.1A)	1.15A	5ef8B-5efnB: 67.6	5ef8B-5efnB: 99.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IWU_A_ERYA404_1 (MACROLIDE 2'-PHOSPHOTRANSFERAS E II)	5efn	HDAC6 PROTEIN (Danio rerio)	4 / 6	GLY B 714 ASP B 610 ILE B 666 TYR B 678	None K B 802 (-3.1A) None None	1.14A	5iwuA-5efnB: undetectable	5iwuA-5efnB: 19.95

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1C3S_A_SHHA952_1","HDLP (HISTONE DEACETYLASE-LIKE PROTEIN)","5efn","HDAC6 PROTEIN","Danio rerio",5,"HIS B 573;HIS B 614;ASP B 705;LEU B 712;TYR B 745","None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None;None","1.20A","1c3sA-5efnB:41.1","1c3sA-5efnB:27.59"],["1C3S_A_SHHA952_1","HDLP (HISTONE DEACETYLASE-LIKE PROTEIN)","5efn","HDAC6 PROTEIN","Danio rerio",9,"PRO B 464;HIS B 573;PHE B 583;ASP B 612;HIS B 614;PHE B 643;ASP B 705;LEU B 712;TYR B 745","None;None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A);None;None","0.55A","1c3sA-5efnB:41.1","1c3sA-5efnB:27.59"],["1FDU_C_ESTC353_1","17-BETA-HYDROXYSTEROID DEHYDROGENASE","5efn","HDAC6 PROTEIN","Danio rerio",5,"GLY B 721;LEU B 725;TYR B 722;GLY B 674;VAL B 686","None","1.09A","1fduC-5efnB:3.6","1fduC-5efnB:23.63"],["1HRK_A_CHDA1502_0","FERROCHELATASE","5efn","HDAC6 PROTEIN","Danio rerio",4,"MET B 687;PRO B 695;VAL B 737;GLY B 735","None","0.95A","1hrkA-5efnB:2.1","1hrkA-5efnB:22.84"],["1HRK_B_CHDB2502_0","FERROCHELATASE","5efn","HDAC6 PROTEIN","Danio rerio",4,"MET B 687;PRO B 695;VAL B 737;GLY B 735","None","0.92A","1hrkB-5efnB:2.1","1hrkB-5efnB:22.84"],["1KB9_A_PCFA514_0","CYTOCHROME B;CYTOCHROME C1, HEME PROTEIN;UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX CORE PROTEIN I;UBIQUINOL-CYTOCHROME C REDUCTASE IRON-SULFUR SUBUNIT","5efn","HDAC6 PROTEIN","Danio rerio",4,"SER B 701;ILE B 622;PHE B 623;VAL B 606","None","0.91A","1kb9A-5efnB:undetectable;1kb9C-5efnB:undetectable;1kb9D-5efnB:undetectable;1kb9E-5efnB:undetectable","1kb9A-5efnB:23.44;1kb9C-5efnB:20.78;1kb9D-5efnB:21.54;1kb9E-5efnB:21.75"],["1MXG_A_ACRA442_1","ALPHA AMYLASE","5efn","HDAC6 PROTEIN","Danio rerio",5,"GLY B 616;GLY B 572;GLY B 703;GLY B 743;ASP B 705","None;None;None; ZN B 801 ( 4.1A); ZN B 801 (-2.6A)","1.12A","1mxgA-5efnB:undetectable","1mxgA-5efnB:22.15"],["1T69_A_SHHA379_1","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",8,"HIS B 573;GLY B 582;PHE B 583;ASP B 612;HIS B 614;PHE B 643;ASP B 705;TYR B 745","None;None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A);None","0.42A","1t69A-5efnB:41.4","1t69A-5efnB:28.54"],["1ZZ1_A_SHHA2452_1","HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE","5efn","HDAC6 PROTEIN","Danio rerio",5,"HIS B 573;HIS B 614;ASP B 705;GLY B 744;TYR B 745","None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None;None","1.24A","1zz1A-5efnB:50.0","1zz1A-5efnB:33.16"],["1ZZ1_A_SHHA2452_1","HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE","5efn","HDAC6 PROTEIN","Danio rerio",8,"HIS B 573;PHE B 583;ASP B 612;HIS B 614;PHE B 643;ASP B 705;GLY B 743;TYR B 745","None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A); ZN B 801 ( 4.1A);None","0.44A","1zz1A-5efnB:50.0","1zz1A-5efnB:33.16"],["1ZZ1_A_SHHA2452_1","HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE","5efn","HDAC6 PROTEIN","Danio rerio",7,"ILE B 532;HIS B 573;ASP B 612;HIS B 614;ASP B 705;GLY B 743;TYR B 745","None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A); ZN B 801 (-2.6A); ZN B 801 ( 4.1A);None","1.06A","1zz1A-5efnB:50.0","1zz1A-5efnB:33.16"],["1ZZ1_B_SHHB2552_1","HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE;HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE","5efn","HDAC6 PROTEIN","Danio rerio",5,"HIS B 573;HIS B 614;ASP B 705;GLY B 743;TYR B 745","None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A); ZN B 801 ( 4.1A);None","1.10A","1zz1B-5efnB:50.5;1zz1C-5efnB:50.4","1zz1B-5efnB:33.16;1zz1C-5efnB:33.16"],["1ZZ1_B_SHHB2552_1","HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE;HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE","5efn","HDAC6 PROTEIN","Danio rerio",8,"HIS B 573;PHE B 583;ASP B 612;HIS B 614;PHE B 643;ASP B 705;GLY B 743;TYR B 745","None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A); ZN B 801 ( 4.1A);None","0.39A","1zz1B-5efnB:50.5;1zz1C-5efnB:50.4","1zz1B-5efnB:33.16;1zz1C-5efnB:33.16"],["1ZZ1_C_SHHC2652_1","HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE","5efn","HDAC6 PROTEIN","Danio rerio",9,"ILE B 532;HIS B 573;GLY B 582;ASP B 612;HIS B 614;PHE B 643;ASP B 705;GLY B 743;TYR B 745","None;None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A); ZN B 801 ( 4.1A);None","1.42A","1zz1C-5efnB:50.4","1zz1C-5efnB:33.16"],["1ZZ1_C_SHHC2652_1","HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE","5efn","HDAC6 PROTEIN","Danio rerio",5,"ILE B 532;HIS B 614;GLY B 582;ASP B 705;GLY B 743","None; ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A); ZN B 801 ( 4.1A)","1.09A","1zz1C-5efnB:50.4","1zz1C-5efnB:33.16"],["1ZZ1_D_SHHD2752_1","HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE","5efn","HDAC6 PROTEIN","Danio rerio",7,"HIS B 573;PHE B 583;ASP B 612;HIS B 614;PHE B 643;ASP B 705;TYR B 745","None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A);None","0.42A","1zz1D-5efnB:50.2","1zz1D-5efnB:33.16"],["1ZZ1_D_SHHD2752_1","HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE","5efn","HDAC6 PROTEIN","Danio rerio",5,"ILE B 532;HIS B 573;ASP B 612;ASP B 705;TYR B 745","None;None; ZN B 801 ( 2.1A); ZN B 801 (-2.6A);None","0.98A","1zz1D-5efnB:50.2","1zz1D-5efnB:33.16"],["2EJ3_A_GBNA2414_1","BRANCHED-CHAIN AMINO ACID AMINOTRANSFERASE","5efn","HDAC6 PROTEIN","Danio rerio",4,"GLY B 618;THR B 588;ALA B 589;ALA B 590","None","0.59A","2ej3A-5efnB:undetectable","2ej3A-5efnB:20.90"],["2OAX_F_SNLF6001_2","MINERALOCORTICOID RECEPTOR","5efn","HDAC6 PROTEIN","Danio rerio",4,"LEU B 732;LEU B 729;MET B 687;MET B 679","None","0.75A","2oaxF-5efnB:undetectable","2oaxF-5efnB:21.11"],["2Y6R_C_CTCC1385_0","TETX2 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",5,"PHE B 583;HIS B 573;GLY B 582;SER B 531;GLY B 713","None","1.36A","2y6rC-5efnB:undetectable","2y6rC-5efnB:21.94"],["3A25_A_SAMA279_1","UNCHARACTERIZED PROTEIN PH0793","5efn","HDAC6 PROTEIN","Danio rerio",3,"MET B 452;GLU B 465;ASP B 705","None;None; ZN B 801 (-2.6A)","1.00A","3a25A-5efnB:undetectable","3a25A-5efnB:23.62"],["3BPX_A_SALA257_1","TRANSCRIPTIONAL REGULATOR;TRANSCRIPTIONAL REGULATOR","5efn","HDAC6 PROTEIN","Danio rerio",4,"ALA B 545;CYH B 549;ILE B 740;THR B 588","None","0.73A","3bpxA-5efnB:undetectable;3bpxB-5efnB:undetectable","3bpxA-5efnB:16.90;3bpxB-5efnB:16.90"],["3C0Z_A_SHHA301_1","HISTONE DEACETYLASE 7A","5efn","HDAC6 PROTEIN","Danio rerio",4,"HIS B 573;ASP B 612;HIS B 614;ASP B 705","None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A); ZN B 801 (-2.6A)","0.10A","3c0zA-5efnB:56.6","3c0zA-5efnB:41.61"],["3C0Z_B_SHHB301_1","HISTONE DEACETYLASE 7A","5efn","HDAC6 PROTEIN","Danio rerio",7,"HIS B 573;PHE B 583;ASP B 612;HIS B 614;PHE B 643;ASP B 705;GLY B 743","None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A); ZN B 801 ( 4.1A)","0.35A","3c0zB-5efnB:56.1","3c0zB-5efnB:41.61"],["3C0Z_B_SHHB301_1","HISTONE DEACETYLASE 7A","5efn","HDAC6 PROTEIN","Danio rerio",4,"PHE B 643;ASP B 705;PHE B 583;ASP B 612","None; ZN B 801 (-2.6A);None; ZN B 801 ( 2.1A)","0.90A","3c0zB-5efnB:56.1","3c0zB-5efnB:41.61"],["3C0Z_C_SHHC301_1","HISTONE DEACETYLASE 7A","5efn","HDAC6 PROTEIN","Danio rerio",4,"HIS B 573;ASP B 612;HIS B 614;ASP B 705","None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A); ZN B 801 (-2.6A)","0.15A","3c0zC-5efnB:56.0","3c0zC-5efnB:41.61"],["3CLB_B_TMQB612_1","DHFR-TS","5efn","HDAC6 PROTEIN","Danio rerio",5,"ALA B 580;ILE B 534;PHE B 586;SER B 514;ILE B 508","None","1.23A","3clbB-5efnB:undetectable","3clbB-5efnB:21.03"],["3CO4_A_GCSA401_1","CHITINASE","5efn","HDAC6 PROTEIN","Danio rerio",3,"GLU B 576;HIS B 573;HIS B 615","EDO B 805 (-4.3A);None;None","0.82A","3co4A-5efnB:undetectable","3co4A-5efnB:19.36"],["3JQ7_B_DX2B271_1","PTERIDINE REDUCTASE 1","5efn","HDAC6 PROTEIN","Danio rerio",4,"ARG B 469;SER B 749;PHE B 704;TYR B 722","None","1.12A","3jq7B-5efnB:5.3","3jq7B-5efnB:22.45"],["3JQA_B_DX4B270_0","PTERIDINE REDUCTASE 1","5efn","HDAC6 PROTEIN","Danio rerio",4,"ARG B 469;SER B 749;PHE B 704;TYR B 722","None","1.11A","3jqaB-5efnB:5.2","3jqaB-5efnB:22.45"],["3JQA_C_DX4C270_0","PTERIDINE REDUCTASE 1","5efn","HDAC6 PROTEIN","Danio rerio",4,"ARG B 469;SER B 749;PHE B 704;TYR B 722","None","1.11A","3jqaC-5efnB:undetectable","3jqaC-5efnB:22.45"],["3JQA_D_DX4D270_0","PTERIDINE REDUCTASE 1","5efn","HDAC6 PROTEIN","Danio rerio",4,"ARG B 469;SER B 749;PHE B 704;TYR B 722","None","1.13A","3jqaD-5efnB:3.0","3jqaD-5efnB:22.45"],["3RUN_A_CCSA165_0","LYSOZYME","5efn","HDAC6 PROTEIN","Danio rerio",3,"ASN B 665;ALA B 649;LYS B 653","None","0.90A","3runA-5efnB:undetectable","3runA-5efnB:17.50"],["3V3N_A_MIYA2001_1","TETX2 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",5,"PHE B 583;HIS B 573;GLY B 582;SER B 531;GLY B 713","None","1.39A","3v3nA-5efnB:1.3","3v3nA-5efnB:24.27"],["3V3N_D_MIYD2001_1","TETX2 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",5,"PHE B 583;HIS B 573;GLY B 582;SER B 531;GLY B 713","None","1.40A","3v3nD-5efnB:undetectable","3v3nD-5efnB:24.27"],["3V3O_C_T1CC401_1","TETX2 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",5,"PHE B 583;HIS B 573;GLY B 582;SER B 531;GLY B 713","None","1.41A","3v3oC-5efnB:undetectable","3v3oC-5efnB:24.27"],["4AFG_C_QMRC1214_1","CAPITELLA TELETA ACHBP;CAPITELLA TELETA ACHBP;CAPITELLA TELETA ACHBP","5efn","HDAC6 PROTEIN","Danio rerio",4,"TYR B 722;CYH B 757;ILE B 567;ILE B 739","None","0.82A","4afgD-5efnB:undetectable;4afgE-5efnB:undetectable","4afgD-5efnB:19.67;4afgE-5efnB:19.67"],["4BBO_C_ACTC1113_0","BLR5658 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",4,"ASN B 617;ALA B 574;GLY B 618;THR B 619","None","1.17A","4bboC-5efnB:undetectable","4bboC-5efnB:15.26"],["4BZ6_A_SHHA700_1","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",7,"HIS B 573;ASP B 612;HIS B 614;ASP B 705;PRO B 711;GLY B 743;TYR B 745","None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None; ZN B 801 ( 4.1A);None","0.39A","4bz6A-5efnB:40.8","4bz6A-5efnB:26.07"],["4BZ6_A_SHHA700_1","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",5,"HIS B 573;HIS B 614;ASP B 705;GLY B 744;TYR B 745","None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None;None","1.22A","4bz6A-5efnB:40.8","4bz6A-5efnB:26.07"],["4BZ6_A_SHHA700_1","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",6,"HIS B 573;HIS B 614;ASP B 705;PRO B 711;GLY B 743;TYR B 745","None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None; ZN B 801 ( 4.1A);None","1.10A","4bz6A-5efnB:40.8","4bz6A-5efnB:26.07"],["4BZ6_B_SHHB700_1","HISTONE DEACETYLASE 8;HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",8,"HIS B 573;ASP B 612;HIS B 614;PHE B 643;ASP B 705;PRO B 711;GLY B 743;TYR B 745","None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A);None; ZN B 801 ( 4.1A);None","0.52A","4bz6A-5efnB:40.8;4bz6B-5efnB:40.6","4bz6A-5efnB:26.07;4bz6B-5efnB:26.07"],["4BZ6_B_SHHB700_1","HISTONE DEACETYLASE 8;HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",5,"HIS B 573;HIS B 614;ASP B 705;GLY B 744;TYR B 745","None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None;None","1.20A","4bz6A-5efnB:40.8;4bz6B-5efnB:40.6","4bz6A-5efnB:26.07;4bz6B-5efnB:26.07"],["4BZ6_B_SHHB700_1","HISTONE DEACETYLASE 8;HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",6,"HIS B 573;HIS B 614;ASP B 705;PRO B 711;GLY B 743;TYR B 745","None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None; ZN B 801 ( 4.1A);None","1.11A","4bz6A-5efnB:40.8;4bz6B-5efnB:40.6","4bz6A-5efnB:26.07;4bz6B-5efnB:26.07"],["4BZ6_C_SHHC700_1","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",9,"HIS B 573;GLY B 582;ASP B 612;HIS B 614;PHE B 643;ASP B 705;PRO B 711;GLY B 743;TYR B 745","None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A);None; ZN B 801 ( 4.1A);None","0.56A","4bz6C-5efnB:40.7","4bz6C-5efnB:26.07"],["4BZ6_C_SHHC700_1","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",5,"HIS B 573;HIS B 614;ASP B 705;GLY B 744;TYR B 745","None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None;None","1.20A","4bz6C-5efnB:40.7","4bz6C-5efnB:26.07"],["4BZ6_C_SHHC700_1","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",6,"HIS B 573;HIS B 614;ASP B 705;PRO B 711;GLY B 743;TYR B 745","None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None; ZN B 801 ( 4.1A);None","1.09A","4bz6C-5efnB:40.7","4bz6C-5efnB:26.07"],["4BZ6_D_SHHD700_1","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",7,"HIS B 573;ASP B 612;HIS B 614;ASP B 705;PRO B 711;GLY B 743;TYR B 745","None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None; ZN B 801 ( 4.1A);None","0.39A","4bz6D-5efnB:40.8","4bz6D-5efnB:26.07"],["4BZ6_D_SHHD700_1","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",5,"HIS B 573;HIS B 614;ASP B 705;GLY B 744;TYR B 745","None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None;None","1.21A","4bz6D-5efnB:40.8","4bz6D-5efnB:26.07"],["4BZ6_D_SHHD700_1","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",6,"HIS B 573;HIS B 614;ASP B 705;PRO B 711;GLY B 743;TYR B 745","None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None; ZN B 801 ( 4.1A);None","1.10A","4bz6D-5efnB:40.8","4bz6D-5efnB:26.07"],["4DJE_A_C2FA300_0","5-METHYLTETRAHYDROFOLATE CORRINOID\/IRON SULFUR PROTEIN METHYLTRANSFERASE","5efn","HDAC6 PROTEIN","Danio rerio",5,"GLU B 465;PHE B 533;ASP B 710;GLY B 744;GLN B 468","None","1.43A","4djeA-5efnB:undetectable","4djeA-5efnB:20.87"],["4LXZ_A_SHHA407_1","HISTONE DEACETYLASE 2","5efn","HDAC6 PROTEIN","Danio rerio",5,"HIS B 463;HIS B 614;ASP B 705;GLY B 744;TYR B 745","None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None;None","1.20A","4lxzA-5efnB:43.7","4lxzA-5efnB:27.82"],["4LXZ_A_SHHA407_1","HISTONE DEACETYLASE 2","5efn","HDAC6 PROTEIN","Danio rerio",10,"HIS B 463;PRO B 464;HIS B 573;GLY B 582;PHE B 583;ASP B 612;HIS B 614;ASP B 705;GLY B 743;TYR B 745","None;None;None;None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A); ZN B 801 (-2.6A); ZN B 801 ( 4.1A);None","0.49A","4lxzA-5efnB:43.7","4lxzA-5efnB:27.82"],["4LXZ_A_SHHA407_1","HISTONE DEACETYLASE 2","5efn","HDAC6 PROTEIN","Danio rerio",5,"HIS B 573;HIS B 614;ASP B 705;GLY B 743;TYR B 745","None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A); ZN B 801 ( 4.1A);None","1.04A","4lxzA-5efnB:43.7","4lxzA-5efnB:27.82"],["4LXZ_B_SHHB408_1","HISTONE DEACETYLASE 2","5efn","HDAC6 PROTEIN","Danio rerio",9,"HIS B 463;PRO B 464;HIS B 573;PHE B 583;ASP B 612;HIS B 614;ASP B 705;GLY B 743;TYR B 745","None;None;None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A); ZN B 801 (-2.6A); ZN B 801 ( 4.1A);None","0.48A","4lxzB-5efnB:43.6","4lxzB-5efnB:27.82"],["4LXZ_B_SHHB408_1","HISTONE DEACETYLASE 2","5efn","HDAC6 PROTEIN","Danio rerio",6,"HIS B 463;PRO B 464;HIS B 614;ASP B 705;GLY B 744;TYR B 745","None;None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None;None","1.18A","4lxzB-5efnB:43.6","4lxzB-5efnB:27.82"],["4LXZ_B_SHHB408_1","HISTONE DEACETYLASE 2","5efn","HDAC6 PROTEIN","Danio rerio",5,"HIS B 573;HIS B 614;ASP B 705;GLY B 743;TYR B 745","None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A); ZN B 801 ( 4.1A);None","1.07A","4lxzB-5efnB:43.6","4lxzB-5efnB:27.82"],["4LXZ_C_SHHC406_1","HISTONE DEACETYLASE 2","5efn","HDAC6 PROTEIN","Danio rerio",5,"HIS B 573;HIS B 614;ASP B 705;GLY B 743;TYR B 745","None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A); ZN B 801 ( 4.1A);None","1.06A","4lxzC-5efnB:43.7","4lxzC-5efnB:27.82"],["4LXZ_C_SHHC406_1","HISTONE DEACETYLASE 2","5efn","HDAC6 PROTEIN","Danio rerio",10,"PRO B 464;HIS B 573;GLY B 582;PHE B 583;ASP B 612;HIS B 614;PHE B 643;ASP B 705;GLY B 743;TYR B 745","None;None;None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A); ZN B 801 ( 4.1A);None","0.43A","4lxzC-5efnB:43.7","4lxzC-5efnB:27.82"],["4LXZ_C_SHHC406_1","HISTONE DEACETYLASE 2","5efn","HDAC6 PROTEIN","Danio rerio",5,"PRO B 464;HIS B 614;ASP B 705;GLY B 744;TYR B 745","None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None;None","1.14A","4lxzC-5efnB:43.7","4lxzC-5efnB:27.82"],["4LXZ_C_SHHC406_1","HISTONE DEACETYLASE 2","5efn","HDAC6 PROTEIN","Danio rerio",5,"PRO B 570;HIS B 614;GLY B 582;ASP B 705;GLY B 743","None; ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A); ZN B 801 ( 4.1A)","1.23A","4lxzC-5efnB:43.7","4lxzC-5efnB:27.82"],["4QA0_A_SHHA404_1","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",9,"HIS B 573;GLY B 582;PHE B 583;ASP B 612;HIS B 614;PHE B 643;ASP B 705;GLY B 743;TYR B 745","None;None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A); ZN B 801 ( 4.1A);None","0.46A","4qa0A-5efnB:41.8","4qa0A-5efnB:27.70"],["4QA0_A_SHHA404_1","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",6,"HIS B 573;PHE B 583;HIS B 614;ASP B 705;GLY B 744;TYR B 745","None;None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None;None","1.22A","4qa0A-5efnB:41.8","4qa0A-5efnB:27.70"],["4QA0_A_SHHA404_1","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",6,"PHE B 583;HIS B 614;PHE B 643;ASP B 705;GLY B 744;TYR B 745","None; ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A);None;None","1.26A","4qa0A-5efnB:41.8","4qa0A-5efnB:27.70"],["4QA0_B_SHHB404_2","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",8,"HIS B 573;PHE B 583;ASP B 612;HIS B 614;PHE B 643;ASP B 705;GLY B 743;TYR B 745","None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A); ZN B 801 ( 4.1A);None","0.50A","4qa0B-5efnB:41.7","4qa0B-5efnB:27.70"],["4QA0_B_SHHB404_2","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",6,"HIS B 573;PHE B 583;HIS B 614;ASP B 705;GLY B 744;TYR B 745","None;None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None;None","1.23A","4qa0B-5efnB:41.7","4qa0B-5efnB:27.70"],["4QA0_B_SHHB404_2","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",6,"PHE B 583;HIS B 614;PHE B 643;ASP B 705;GLY B 744;TYR B 745","None; ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A);None;None","1.25A","4qa0B-5efnB:41.7","4qa0B-5efnB:27.70"],["4QA2_A_SHHA404_1","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",9,"HIS B 573;GLY B 582;PHE B 583;ASP B 612;HIS B 614;PHE B 643;ASP B 705;GLY B 743;TYR B 745","None;None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A); ZN B 801 ( 4.1A);None","0.48A","4qa2A-5efnB:41.6","4qa2A-5efnB:27.94"],["4QA2_A_SHHA404_1","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",5,"HIS B 573;HIS B 614;ASP B 705;GLY B 744;TYR B 745","None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None;None","1.20A","4qa2A-5efnB:41.6","4qa2A-5efnB:27.94"],["4QA2_A_SHHA404_1","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",6,"PHE B 583;HIS B 614;PHE B 643;ASP B 705;GLY B 744;TYR B 745","None; ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A);None;None","1.23A","4qa2A-5efnB:41.6","4qa2A-5efnB:27.94"],["4QA2_B_SHHB404_1","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",9,"HIS B 573;GLY B 582;PHE B 583;ASP B 612;HIS B 614;PHE B 643;ASP B 705;GLY B 743;TYR B 745","None;None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A); ZN B 801 ( 4.1A);None","0.44A","4qa2B-5efnB:41.9","4qa2B-5efnB:27.94"],["4QA2_B_SHHB404_1","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",5,"HIS B 573;HIS B 614;ASP B 705;GLY B 744;TYR B 745","None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None;None","1.20A","4qa2B-5efnB:41.9","4qa2B-5efnB:27.94"],["4QA2_B_SHHB404_1","HISTONE DEACETYLASE 8","5efn","HDAC6 PROTEIN","Danio rerio",6,"PHE B 583;HIS B 614;PHE B 643;ASP B 705;GLY B 744;TYR B 745","None; ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A);None;None","1.22A","4qa2B-5efnB:41.9","4qa2B-5efnB:27.94"],["5EEI_A_SHHA2004_1","HDAC6 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",6,"PRO B 464;HIS B 573;HIS B 614;ASP B 705;LEU B 712;TYR B 745","None;None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None;None","1.03A","5eeiA-5efnB:69.6","5eeiA-5efnB:99.73"],["5EEI_A_SHHA2004_1","HDAC6 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",11,"PRO B 464;SER B 531;HIS B 573;GLY B 582;PHE B 583;ASP B 612;HIS B 614;PHE B 643;ASP B 705;LEU B 712;TYR B 745","None;None;None;None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A);None;None","0.47A","5eeiA-5efnB:69.6","5eeiA-5efnB:99.73"],["5EEI_B_SHHB801_1","HDAC6 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",6,"PRO B 464;HIS B 573;HIS B 614;ASP B 705;LEU B 712;TYR B 745","None;None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None;None","1.03A","5eeiB-5efnB:68.3","5eeiB-5efnB:99.73"],["5EEI_B_SHHB801_1","HDAC6 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",11,"PRO B 464;SER B 531;HIS B 573;GLY B 582;PHE B 583;ASP B 612;HIS B 614;PHE B 643;ASP B 705;LEU B 712;TYR B 745","None;None;None;None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A);None;None","0.47A","5eeiB-5efnB:68.3","5eeiB-5efnB:99.73"],["5EEN_A_5OGA804_1","HDAC6 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",6,"HIS B 463;HIS B 614;PHE B 643;ASP B 705;GLY B 744;TYR B 745","None; ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A);None;None","1.27A","5eenA-5efnB:68.2","5eenA-5efnB:99.73"],["5EEN_A_5OGA804_1","HDAC6 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",10,"HIS B 463;PRO B 464;HIS B 573;PHE B 583;ASP B 612;HIS B 614;PHE B 643;ASP B 705;GLY B 743;TYR B 745","None;None;None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A); ZN B 801 ( 4.1A);None","0.23A","5eenA-5efnB:68.2","5eenA-5efnB:99.73"],["5EEN_A_5OGA804_1","HDAC6 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",5,"HIS B 573;ASP B 612;HIS B 614;ASP B 705;GLY B 703","None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None","1.19A","5eenA-5efnB:68.2","5eenA-5efnB:99.73"],["5EEN_A_5OGA804_1","HDAC6 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",6,"PRO B 464;HIS B 573;HIS B 614;ASP B 705;GLY B 743;TYR B 745","None;None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A); ZN B 801 ( 4.1A);None","1.11A","5eenA-5efnB:68.2","5eenA-5efnB:99.73"],["5EEN_A_5OGA804_1","HDAC6 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",8,"SER B 531;HIS B 573;PHE B 583;ASP B 612;HIS B 614;PHE B 643;ASP B 705;GLY B 743","None;None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A); ZN B 801 ( 4.1A)","0.59A","5eenA-5efnB:68.2","5eenA-5efnB:99.73"],["5EEN_A_5OGA804_1","HDAC6 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",5,"SER B 531;PHE B 643;ASP B 705;PHE B 583;ASP B 612","None;None; ZN B 801 (-2.6A);None; ZN B 801 ( 2.1A)","1.17A","5eenA-5efnB:68.2","5eenA-5efnB:99.73"],["5EEN_B_5OGB804_1","HDAC6 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",10,"HIS B 463;PRO B 464;HIS B 573;PHE B 583;ASP B 612;HIS B 614;PHE B 643;ASP B 705;LEU B 712;TYR B 745","None;None;None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A);None;None","0.29A","5eenB-5efnB:67.7","5eenB-5efnB:99.73"],["5EEN_B_5OGB804_1","HDAC6 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",6,"PRO B 464;HIS B 573;HIS B 614;ASP B 705;LEU B 712;TYR B 745","None;None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None;None","1.01A","5eenB-5efnB:67.7","5eenB-5efnB:99.73"],["5EEN_B_5OGB804_1","HDAC6 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",9,"SER B 531;HIS B 573;PHE B 583;ASP B 612;HIS B 614;PHE B 643;ASP B 705;LEU B 712;TYR B 745","None;None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A);None;None","0.57A","5eenB-5efnB:67.7","5eenB-5efnB:99.73"],["5EEN_B_5OGB804_1","HDAC6 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",5,"SER B 531;PHE B 643;ASP B 705;PHE B 583;ASP B 612","None;None; ZN B 801 (-2.6A);None; ZN B 801 ( 2.1A)","1.17A","5eenB-5efnB:67.7","5eenB-5efnB:99.73"],["5EF8_A_LBHA2004_1","HDAC6 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",10,"ASP B 460;HIS B 463;PRO B 464;HIS B 573;PHE B 583;ASP B 612;HIS B 614;PHE B 643;ASP B 705;TYR B 745","None;None;None;None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A);None","0.22A","5ef8A-5efnB:67.6","5ef8A-5efnB:99.73"],["5EF8_A_LBHA2004_1","HDAC6 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",9,"ASP B 460;SER B 531;HIS B 573;PHE B 583;ASP B 612;HIS B 614;PHE B 643;ASP B 705;TYR B 745","None;None;None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A);None","0.54A","5ef8A-5efnB:67.6","5ef8A-5efnB:99.73"],["5EF8_A_LBHA2004_1","HDAC6 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",5,"SER B 531;PHE B 643;ASP B 705;PHE B 583;ASP B 612","None;None; ZN B 801 (-2.6A);None; ZN B 801 ( 2.1A)","1.16A","5ef8A-5efnB:67.6","5ef8A-5efnB:99.73"],["5EF8_B_LBHB2004_1","HDAC6 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",10,"ASP B 460;PRO B 464;HIS B 573;PHE B 583;ASP B 612;HIS B 614;PHE B 643;ASP B 705;LEU B 712;TYR B 745","None;None;None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A);None;None","0.29A","5ef8B-5efnB:67.6","5ef8B-5efnB:99.73"],["5EF8_B_LBHB2004_1","HDAC6 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",10,"ASP B 460;SER B 531;HIS B 573;PHE B 583;ASP B 612;HIS B 614;PHE B 643;ASP B 705;LEU B 712;TYR B 745","None;None;None;None; ZN B 801 ( 2.1A); ZN B 801 ( 3.2A);None; ZN B 801 (-2.6A);None;None","0.55A","5ef8B-5efnB:67.6","5ef8B-5efnB:99.73"],["5EF8_B_LBHB2004_1","HDAC6 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",6,"PRO B 464;HIS B 573;HIS B 614;ASP B 705;LEU B 712;TYR B 745","None;None; ZN B 801 ( 3.2A); ZN B 801 (-2.6A);None;None","0.98A","5ef8B-5efnB:67.6","5ef8B-5efnB:99.73"],["5EF8_B_LBHB2004_1","HDAC6 PROTEIN","5efn","HDAC6 PROTEIN","Danio rerio",5,"SER B 531;PHE B 643;ASP B 705;PHE B 583;ASP B 612","None;None; ZN B 801 (-2.6A);None; ZN B 801 ( 2.1A)","1.15A","5ef8B-5efnB:67.6","5ef8B-5efnB:99.73"],["5IWU_A_ERYA404_1","MACROLIDE 2'-PHOSPHOTRANSFERASE II","5efn","HDAC6 PROTEIN","Danio rerio",4,"GLY B 714;ASP B 610;ILE B 666;TYR B 678","None;  K B 802 (-3.1A);None;None","1.14A","5iwuA-5efnB:undetectable","5iwuA-5efnB:19.95"]]